Aims/hypothesis On the basis of our previous studies, we investigated the possible role of focal adhesion kinase (FAK) in the development of insulin resistance in skeletal muscle, a major organ responsible for insulin-stimulated glucose uptake. Materials and methods Insulin-resistant C2C12 skeletal muscle cells were transfected with FAK wild-type or FAK mutant plasmids, knocked down using small interfering RNA (siRNA), and their effects on the levels and activities of insulin-signalling molecules and on glucose uptake were determined. Results A significant decrease in tyrosine phosphorylation of FAK in insulin-resistant C2C12 cells was observed. A similar decrease was observed in skeletal muscle obtained from insulin-resistant Sprague-Dawley rats fed a high-fat diet. Increased levels of FAK in insulin-resistant C2C12 skeletal muscle cells increased insulin sensitivity and glucose uptake. These effects were reversed by an increase in the level of kinase activity mutant FAK or suppression of endogenous FAK by siRNA. FAK was also found to interact downstream with insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase C and glycogen synthase kinase 3β, leading to translocation of glucose transporter 4 and resulting in the regulation of glucose uptake. Conclusions/interpretation The present study provides strong evidence that the modulation of FAK level regulates the insulin sensitivity of skeletal muscle cells. The results demonstrate a direct role of FAK in insulin-resistant skeletal muscle cells for the first time.
Introduction
Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase and is known to play a key role in integrin signalling [1] . FAK can associate with multiple cellular components, including adhesion-associated proteins and signalling molecules [2] . We have previously reported regulation of myogenesis [3, 4] and cell spreading [5, 6] by FAK as a function of its tyrosine phosphorylation in C2C12 skeletal muscle cells due to insulin stimulation. Bianchi et al. [7] reported the regulation of FAK phosphorylation by glycogen synthase kinase 3β (GSK-3β) during cell spreading and migration. In addition, regulation of FAK phosphorylation by insulin stimulation in non-muscle cells has been reported [8] [9] [10] . A regulatory role of FAK in IRS-1 levels [11, 12] and hepatic insulin action [13, 14] has also been reported. Genetic studies have provided evidence for interaction between integrin and insulin signalling [15, 16] . The available literature also focuses on the role of FAK in insulin-mediated effects on the cytoskeleton [10, 17] . Recently, Huang et al. [18] have reported that a reduced level of FAK disrupts insulin action in skeletal muscle. However, the role of FAK in regulating insulin resistance in skeletal muscle, if any, and its possible pathway have not been investigated.
We had previously generated an insulin-resistant skeletal muscle model by differentiating mouse C2C12 cells in the chronic presence of insulin (100 nmol/l) in serum-free medium (MFI) [19] [20] [21] [22] . The model was validated using glucose-lowering drugs, including pioglitazone [19] , metformin [20] and gliclazide [21] . This model was used in the present study to investigate the role of FAK, if any, under conditions of impaired insulin action.
Materials and methods
Materials Nutrient Mixture F-12 Ham, MCDB 201 medium and 2-deoxy [ 3 H]glucose (2-DOG) were from Sigma Chemical Company (St Louis, MO, USA). Anti-phospho Akt (Ser473), anti-Akt, anti-phospho (Ser) GSK-3β and anti-GSK-3β antibodies were from Cell Signaling Technology (MA, USA). Anti-FAK, anti-phosphotyrosine, antiinsulin receptor (IR) and anti-IRS-1 antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Bovine insulin and anti-GLUT4 (also known as SLC2A2) was purchased from Calbiochem (CA, USA). All other reagents were from Sigma unless attributed otherwise.
Cell culture C2C12 skeletal muscle cell lines (wild-type and transfectants) were maintained in DMEM supplemented with 15% FCS containing penicillin 100 IU/ml and streptomycin 100 μg/ml in 5% CO 2 at 37°C [3] . Cells at 70% confluence were differentiated in an equal mixture of MCDB 201 and Ham's F-12 medium as described previously [19] in the absence (MF, insulin-sensitive condition) or in the chronic presence of 100 nmol/l insulin (MFI, insulin-resistant condition) for 3 days.
Subcellular fractionation C2C12 myotubes, pretreated with or without insulin, were washed with ice-cold PBS, scraped into buffer A (mmol/l: HEPES 20, pH 7.4, sucrose 250, EDTA 1, phenylmethylsulphonyl fluoride [PMSF] 2) with 10 μg/ml aprotinin and leupeptin and homogenised for 10 min at 4°C, after which low-density microsome (LDM) and plasma membrane fractions were isolated by differential centrifugation [23] . Protein samples (100 μg) were subjected to SDS-PAGE and western immunoblotting.
Transfection of plasmid vectors C2C12 cells were stably transfected with FAK wild-type and mutant plasmids as described earlier [22] .
siRNA transfection siRNA oligonucleotides against FAK targeted sequence 5′-TGCAATGGAACGAGTATTAAA-3′ were designed and synthesised by Qiagen GmbH (Hilden, Germany). C2C12 cells were transiently transfected with FAKspecific and non-specific siRNA (400 nmol/l) using RNAifect transfection reagent (Qiagen) in reduced-serum Opti-MEM media (Gibco BRL, Carlsbad, CA, USA) according to the manufacturer's instructions, with minor modifications.
Preparation of cell lysates Cells were washed with ice-cold PBS and lysed in lysis buffer (mmol/l: HEPES 50, pH 7.4, NaCl 150, MgCl 2 1.5, EGTA 1, sodium pyrophosphate 10, sodium fluoride 50, β-glycerophosphate 50, Na 3 VO 4 1, PMSF 2) with 1% Triton X-100, 10 μg/ml each of leupeptin, aprotonin and soyabean trypsin inhibitor at 4°C for 30 min. Homogenates were centrifuged at 16,000 g for 15 min at 4°C [4] . Protein estimation was performed using the Bicinchoninic Acid Kit (Sigma) according to the manufacturer's instructions. Equal concentrations of lysates of all the samples were subjected to SDS-PAGE followed by western immunoblotting [3] .
Tissue preparation from rats fed a high-fat diet Male Sprague-Dawley rats (Central Animal Facility, NIPER, India) were divided into two equal groups. One of the groups was fed a normal pellet diet, while the other group was fed a high-fat diet for 4 weeks. The high-fat diet comprised: powdered pellets (364 g), lard (310 g), casein (250 g), cholesterol (10 g), DL-methionine (3 g), Yee-sac powder (1 g), vitamin and mineral mix powder (60 g), sodium chloride (2 g). Biochemical analyses and tolerance tests were performed as described previously [24, 25] . Skeletal muscle from the thigh region was collected, washed with PBS (pH 7.4) and lysed using the lysis buffer as described earlier [4] . The use of animals for the experiments was in compliance with the guidelines of our institutional animal ethics committee.
Phosphatidyl inositol 3-kinase activity Cells were differentiated under MF and MFI conditions and were stimulated with insulin for 10 min. Cells (500 μg) were lysed and immunoprecipitated for IRS-1 [19] . IRS-1-associated activity of phosphatidyl inositol 3-kinase (PI3K) was determined with the PI3K ELISA Kit (Echelon Biosciences Inc., Salt Lake City, UT, USA) according to the manufacturer's instructions and as reported previously [26] [27] [28] .
Glucose uptake assays Glucose uptake assays were performed using 2-DOG as described earlier [21] .
Densitometric analysis Relative densitometric analyses of the samples were determined using Gel Doc 2000 (BioRad, Hercules, CA, USA) and Quantity One 1-D analysis software (Bio-Rad) by giving an arbitrary value of 1.0 to the respective control samples of each experiment, keeping the background value as 0.
Statistical analysis
The data are expressed as mean±SE. For comparison of two groups, p values were calculated using the two-tailed unpaired Student's t test. In all the cases p<0.05 was considered to be statistically significant.
Results
To determine the role of FAK in insulin resistance, if any, C2C12 cells were differentiated under insulin-sensitive (MF) or insulin-resistant (MFI) conditions [19] . Cells were lysed, immunoprecipitated with anti-FAK and subjected to western immunoblotting with anti-phosphotyrosine or anti-FAK antibody (Fig. 1a) . FAK tyrosine phosphorylation was found to be reduced by 40.3±0.01% in insulin-resistant cells, with no change in its protein level (Fig. 1a) . To determine whether FAK tyrosine phosphorylation is affected in insulin-resistant animals, skeletal muscles were isolated from the high-fat-diet-fed Sprague-Dawley rats [24, 25] and examined for FAK phosphorylation. Rats fed high-fat diets show significant elevations in body weight, plasma insulin, plasma glucose, plasma triacylglycerol and plasma cholesterol levels, resulting in insulin resistance [24, 25] . Skeletal muscle isolated from normal and high-fat-dietfed Sprague-Dawley rats were immunoprecipitated with anti-FAK and subjected to western immunoblotting with anti-phosphotyrosine or anti-FAK antibody. A decrease (57.5±0.04%) in tyrosine phosphorylation was observed in high-fat-diet-fed Sprague-Dawley rats compared with normal rats (Fig. 1b) , with no change in its protein level (Fig. 1b) . The data thus confirmed the in vitro findings and strongly emphasised the possible involvement of FAK in skeletal muscle insulin resistance.
The role of FAK could be shown either by generating FAK knockout mice or use specific inhibitors. However, FAK knockout studies could not be performed because of reported embryonic lethality [29, 30] and there is no inhibitor of FAK available [2] . Therefore, to address the issue we undertook several lines of study. We generated the C2C12 cell line, which overexpresses haemagglutinin (HA)-tagged plasmid constructs containing the wild-type gene encoding FAK (C2FAK (Fig. 2a) . No significant change in cellular morphology (ESM Fig. 2) , growth rates and cell death due to transfection was observed, as shown by Trypan Blue exclusion and the TUNEL (terminal deoxyribonucleotide transferase-mediated dUTP nick end labelling) assay (data not shown). Transfected cells were then subjected to the MF and MFI conditions and tyrosine phosphorylation of FAK was assayed (Fig. 2b) . Under both conditions, tyrosine phosphorylation of C2FAK
wt/+ cells increased by 56±0.06 and 42.2±0.03% over their respective controls (Fig. 2b, To further establish the role of FAK, the siRNA approach was used. Maximum downregulation (84.6± 0.01%) of FAK was observed at 400 nmol/l of siRNA (ESM Fig. 4a ), specific to FAK (ESM Fig. 4b ), without affecting cellular morphology (ESM Fig. 5 ), viability and growth rate (data not shown). We next studied the effect of FAK downregulation under the MF and MFI conditions with and without insulin stimulation. The level and phosphorylation of FAK in siRNA-transfected cells remained downregulated under all the culture conditions ( Fig. 3a, ESM Fig. 6 ). Next, we examined the effect of FAK silencing on insulin-stimulated glucose uptake in siRNA-transfected cells (C2siRNAFAK wt ) differentiated under the MF and MFI conditions (Fig. 3b ). Basal and Fig. 7) . siRNA knock-down further supports the idea that elimination of FAK decreases cellular glucose uptake, which might be a consequence of impaired insulin signalling. To further substantiate our results, FAK was silenced in L6E9 cells, which are known to have a greater concentration of glucose transporter than C2C12 cells, and the cells were used in experiments similar to those described above. Basal and insulin-stimulated glucose uptake was both substantially reduced in FAK-silenced L6E9 cells (L6siRNAFAK wt ) compared with non-silenced wild-type cells (L6FAK wt ) (ESM Fig. 8 ). The data suggest that the FAK is necessary for insulin-stimulated glucose uptake in L6E9 cells, as observed in the C2C12 cell line.
We next examined the potential molecular mechanisms that might underlie the protection from insulin resistance conferred by an increased level of FAK and corresponding tyrosine phosphorylation. The possible mechanisms include increased insulin-mediated activation of the IR and/or its downstream molecules. Therefore, we examined IR-β tyrosine phosphorylation and production in C2FAK To explore the role(s) of FAK in regulating downstream molecules, IRS-1-associated PI3K activity was determined. In C2FAK
wt/+ cells, insulin-stimulated PI3K activity increased 1.7±0.29-fold in the MF condition (Fig. 4c , lane 4 Insulin-stimulated IRS-1-associated PI3K activity was unaltered in C2FAK mut/+ cells under the MFI condition (Fig. 4c, lane 12 [34, 35] . Therefore, insulinstimulated activation, if any, of Akt was examined in all the cell lines (Fig. 4e) . No additional insulin-stimulated effect of Akt phosphorylation (Ser473) was observed in C2FAK wt/+ cells (Fig. 4e, PKC is reported to regulate glucose uptake downstream of PI3K [34, 35] . Therefore, insulin-stimulated activation of PKC, if any, was tested in all the cell lines by probing with anti-phospho pan-PKC antibody. Insulin-stimulated PKC phosphorylation of C2FAK wt/+ cells increased (by 21.4±0.05%) under the MF condition (Fig. 4g, lane 4 vs lane 2, p < 0.01) but decreased (by 37.4 ± 0.03%) in C2FAK mut/+ cells (Fig. 4g, lane 6 vs lane 2, p<0.01) , and the level of activation was similar to that in insulin-resistant C2FAK wt cells (Fig. 4g, lane 6 vs lane 8) . Insulinstimulated PKC phosphorylation increased (76.3±0.03%) in C2FAK
wt/+ cells under the MFI condition (Fig. 4g, lane  10 vs lane 8, p<0.01) , and the extent of activation was as observed in insulin-sensitive C2FAK wt cells (Fig. 4g , lane 10 vs lane 2), whereas it was further decreased (37.5± 0.01%) in C2FAK mut/+ cells (Fig. 4g , lane 12 vs lane 8, p<0.01) without affecting its protein level (Fig. 4g) . PKC phosphorylation of C2siRNAFAK wt cells decreased by 62.6±0.02 and 56±0.01% under the MF and MFI conditions, respectively (Fig. 4h, To evaluate the contribution of PKC to glucose uptake, we downregulated the level of PKC by differentiating C2FAK wt , C2FAK
wt/+ and C2FAK mut/+ cells under prolonged exposure (3 days) to 100 nmol/l phorbol 12,13-dibutyrate (PDBu) [4, 36] . PKC protein level (Fig. 5a) and phosphorylation (Fig. 5b) were completely inhibited under all the conditions examined. A significant decrease in insulin-stimulated glucose uptake was observed in all the cell lines treated with PDBu (Fig. 5c ). Similar effects on PKC level/phosphorylation (Fig. 5d,e) and glucose uptake (Fig. 5f) were observed in C2siRNAFAK wt cells treated with PDBu. The data suggest that PKC is the downstream molecule responsible for FAK-mediated glucose uptake.
FAK was previously reported to regulate the activity of GSK-3β (a regulatory enzyme upstream of glycogen synthase) in hepatocytes, [7, 13] . To determine whether the observed effect of an increased level of FAK was accompanied by GSK-3β activation, insulin-stimulated Ser-9 phosphorylation of GSK-3β was examined. C2FAK
wt/+ cells increased insulin-stimulated GSK-3β phosphorylation under the MF condition (by 27.8±0.05%; Fig. 6a , lane 4 vs lane 2, p < 0.01), whereas phosphorylation was decreased in C2FAK mut/+ cells (by 32.4±0.03%; Fig. 6a , lane 6 vs lane 2, p<0.01) compared with insulin-resistant C2FAK wt cells (Fig. 6a, lane 6 vs lane 8) . C2FAK
wt/+ cells showed increased (by 49.3±0.03%) GSK-3β phosphorylation under the MFI condition (Fig. 6a, lane 10 vs lane 8, p<0.01) , and the level of phosphorylation was similar to that observed in insulinsensitive C2FAK wt cells (Fig. 6a, lane 10 vs lane 2) , whereas it was further decreased (by 21.5±0.01%) in C2FAK mut/+ cells (Fig. 6a, The data suggest anabolism between enhanced glucose uptake and glycogen synthesis as a result of increased GSK-3β phosphorylation due to FAK overproduction. Since no change in the level of GLUT4 was observed in any of the cell lines under any condition (Fig. 7a,b) , insulin-stimulated translocation of GLUT4 was examined in subcellular fractions (LDM and plasma membrane). We observed a 32.0±0.12% increase in GLUT4 translocation to the plasma membrane fraction of C2FAK wt/+ cells under the MF condition (Fig. 7c, lanes 7 and 8 vs lanes 3 and 4) , indicating enhanced insulin-stimulated GLUT4 translocation due to an increased level of FAK. In contrast, GLUT4 molecules remained in the LDM fraction in insulinsensitive C2FAK mut/+ cells (Fig. 7c , lanes 9 and 10 vs lanes 1 and 2). Under the MFI condition, maximum translocation was observed in C2FAK wt/+ cells (Fig. 7d , lanes 7 and 8 vs lanes 3 and 4) and almost no translocation was observed in C2FAK mut/+ cells (Fig. 7d, lanes 11 and 12  vs lanes 1 and 2) . Insulin-stimulated incremental GLUT4 translocation was significantly impaired in C2siRNAFAK (Fig. 7e, 
Discussion
In the present study a direct correlation was observed between FAK protein level/phosphorylation and glucose uptake in the presence of insulin, suggesting insulindependent regulation of insulin resistance in C2C12 skeletal muscle cells by FAK. Huang et al. [18] reported that downregulation of FAK affects only insulin-stimulated glucose uptake, unlike the observations in our study (Fig. 3b) . One of the possible explanations for this could be that Huang et al. reported glucose uptake when there was 53% downregulation in the level of FAK, leaving approximately 47% of the endogenous FAK available, whereas in our study 85% of the FAK was downregulated, thus eliminating any significant contribution of the endogenous protein. Under our experimental conditions, the mechanism of FAK-mediated regulation of insulin resistance could be the interaction of FAK with unidentified substrate(s) that becomes activated only in the presence of insulin and is necessary for the interaction between FAK and insulin signalling molecules. The observed increase in tyrosine phosphorylation in the basal condition of overexpressed FAK might be due to activation by other stimuli.
Like us, Annabi et al. [31] and Huang et al. [14] also observed no interaction between FAK and the IR in their studies, using CHO and HepG2 cells. However, we observed that up-or downregulation of FAK activity correspondingly affected insulin-stimulated glucose uptake via the IRS-1/PI3K pathway. Therefore, our results indicate that FAK regulates insulin signalling upstream of IRS-1 and then regulates the cascade downstream via PI3K. Insulin signalling without involving the IR, via IRS-1, has been reported previously in other non-receptor tyrosine kinases, pp59Lyn in 3T3-adipocytes [37] . FAK is also reported to interact with cytosolic tyrosine kinase Src, which can regulate IRS-1 tyrosine phosphorylation in CHO cells [33] . In human embryo kidney cells, Lebrun et al. [33] have reported that FAK can phosphorylate IRS-1 without the participation of Src.
In our study, the mechanism whereby mutant FAK inhibits the ability of insulin to induce phosphorylation of Akt remains unclear. It is possible that endogenous FAK interacts with unidentified protein(s) necessary for interaction with Akt. Mutant FAK possibly exerts a dominant negative effect on endogenous FAK. A similar dissociation between these two proteins has been reported previously in hepatocytes [14] . However, an increased level of FAK wt did not restore Akt phosphorylation under insulin-resistant conditions even though tyrosine phosphorylation of IRS-1 and PI3K activation was restored. A possible explanation includes additional regulation of Akt independently of PI3K in the insulin-resistant condition. Lin et al. [38] found that PKC activator decreased the ability of insulin to phosphorylate both Akt and GSK-3β in rat skeletal muscle, whereas PI3K activation was unaffected.
Decreased glucose uptake irrespective of an increased or decreased level of FAK under conditions of PKC inhibition indicates a markedly smaller contribution of Akt. Therefore, in the insulin-resistant condition the signal travels mainly through activated PI3K to PKC rather than to Akt. Earlier reports have suggested that phosphatidylinositol (3,4,5)-triphosphate (PIP3) produced by PI3K, responsible for both Akt and PKC phosphorylation, has more affinity for PKC than Akt [34] . Moreover, in the insulin-resistant condition PKC downregulates Akt and this is unaccompanied by a change in PI3K activity in skeletal muscle cells [37] . Therefore, it is possible that FAK differentially regulates insulin signalling under normal and insulinresistant conditions. Sajan et al. [39] recently reported a differential role of the atypical PKC isoforms ζ and λ in insulin-stimulated glucose transport. Regulation of GLUT4 translocation in skeletal muscle of high-fat-diet-fed rats by PKC (ζ/λ) has also been reported [40] . Therefore, there is a possibility of FAK-regulated activity of PKC ζ/λ, or any other isoform(s), in regulating insulin resistance. Further studies are in progress to determine the specific isoform(s) that may be responsible for interacting with FAK to regulate the pathway.
It has been reported that modulation of FAK level in hepatocytes regulates glycogen synthesis [7, 14] . We also observed that up-or downregulation of FAK correspondingly phosphorylates GSK-3β, implying the regulation of glycogen synthesis by FAK in these cells.
Kotliar and Pilch [41] observed that the increased level of GLUT4 fails to reconstitute insulin-stimulated glucose transporter in C2C12 cells and postulated the requirement for additional gene(s) to form functional translocating vesicles. Microtubules have been reported to be required for the translocation of GLUT4 [18, [42] [43] [44] [45] [46] . FAK is required for the stabilisation of microtubules in fibroblasts [47] and its tyrosine phosphorylation is essential for the insulin-stimulated rearrangement of actin fibres in CHO/IR cells [10] . Huang et al. [18] reported that FAK regulates insulin-mediated cytoskeletal rearrangement essential for normal glucose transport and glycogen synthesis. There-fore, the observed increase in glucose uptake as a result of increased FAK level with no change in expression in our study is possibly due to the enhanced recruitment of actin filament and microtubules responsible for the GLUT4 translocation. Further studies are in progress to demonstrate interaction between GLUT, microtubules and FAK.
In summary, the present study demonstrates a novel role for FAK as a positive regulator of the insulin signalling pathway, leading to glucose transport and insulin sensitisation. This conclusion is based on the following findings: (1) in the insulin-resistant condition FAK was always found to be less active; (2) downregulation of FAK activity resulted in impaired insulin signalling; (3) decreased glucose uptake was a consequence of impaired insulin signalling due to downregulation of FAK; and (4) increased level of FAK in the insulin-resistant condition reversed all the above-mentioned observations. The stimulatory effect of FAK on insulinstimulated glucose transport involves the IRS-1/PI3K/PKC arm of the insulin signalling pathway. Interestingly, IR and Akt do not seem to contribute to the pathway. Since an increase in FAK and its phosphorylation sensitises C2C12 skeletal muscle cells to insulin stimulation of GLUT4 translocation and glucose transport, these results further support a role for an insulin-stimulated FAK/IRS-1/PI3K/ PKC signalling pathway as a physiologically important mediator of the action of insulin. Since increased levels of FAK leads to cellular insulin sensitisation, these results also raise the possibility that interfering with FAK production or activation may provide opportunities for developing new therapeutic strategies against insulin resistance. Chemical activators of FAK would be expected to act as insulin sensitisers, which could have beneficial effects in insulin resistance induced by hyperinsulinaemia. This opens up the possibility of new therapeutic intervention.
